NICE, France--(BUSINESS WIRE)--Harbinger Medical Inc.™ of Minneapolis, Minnesota USA today announced the results of a study presented at the 2008 Cardiostim meeting in Nice. Four abstracts, including two poster workshops by the study’s primary investigator Dr. Peter Brady, FRCP, Mayo Clinic, Rochester MN, showed that a Wedensky Modulation Index identified more than 80 percent of all life-threatening arrhythmic events that occurred in the study population.
